Global Contrast Media Market Set for Rapid Growth, to reach Value around USD 6.32 Billion by 2025

Zion Market Research has published a new report titled “Contrast Media Market by Type (Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media and Microbubble Contrast Media), Modality (X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Ultrasound),route of administration (Oral, Intravascular, Rectal and Other Routes), indication (Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders and Others), application (radiology, interventional radiology, interventional cardiology and others),  and end user (hospitals, diagnostic centers, research & academic institutes and other end users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025”. 

According to the report, global demand for Contrast Media Market was valued at approximately USD 4.74 Billion in 2018, and is expected to generate revenue of around USD 6.32 Billion by end of 2025, growing at a CAGR of around 4.19 % between 2018 and 2025.

Browse the full “Contrast Media Market: by Type (Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media and Microbubble Contrast Media), Modality (X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Ultrasound),route of administration (Oral, Intravascular, Rectal and Other Routes), indication (Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders and Others), application (radiology, interventional radiology, interventional cardiology and others),  and end user (hospitals, diagnostic centers, research & academic institutes and other end users)– Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025” Report at https://www.zionmarketresearch.com/report/contrast-media-industry 

Contrast media is used to enhance blood and tissue perfusion, also known as contrast agents. It includes iodine-based contrast dependent on computed tomography (CT), gadolinium-based MRI-based agents, and lipid bubble contrast agents used in ultrasound. Contrast agents absorb or modify external electromagnetism or ultrasound, which is distinct from radiopharmaceuticals that emit radiation themselves. Forx-rays, contrast agents that improve radiodensity in a target tissue or structure. In MRIs, contrast agents shorten (or in some cases increase) the duration of nuclei relaxation within the tissues of the body to change the contrast in the image.

The growing need for image refinement during surgery, as well as demand, needs new methods of data acquisition, processing and display, as well as a full understanding of the imaging process and its applications for therapy. This need is well served by image-guided procedures, leading to increased demand for image-guided diagnostic and treatment procedures, thus acting as a factor of market growth.

The market for Contrast Media is segmented based on Type, Modality, route of administration, indication, application, end user and region. Based on Type, the market is segmented into Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media and Microbubble Contrast Media. The iodine contrast media segment is expected to hold the largest proportion of the contrast media market in 2018. The high proportion of this segment can be attributed because of its strong use in CT studies, coupled with the fact that it can be used in almost all body parts. 

Based on Modality, the market is segmented into X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Ultrasound. X-ray / CT procedures are expected to command the largest share of the global demand for media contrast in 2018. The ultrasound segment is expected to grow at the fastest CAGR, however. Growth in the ultrasound segment can be largely due to several benefits offered by ultrasound contrast agents relative to other contrast agents and the increasing number of penalties in the ultrasound contrast agents in U.S., Europe and Japan.

Based on route of administration, the market is segmented into Oral, Intravascular, Rectal and Other Routes. The intravascular route segment is expected to dominate the largest proportion of the contrast media market in 2018. This segment is also expected to grow at the fastest CAGR. Growth in this segment can largely be attributed to developments in CT and MRI imaging techniques that use mainly the intravascular pathway to inject contrast information.

Based on Indication, the contrast media market is classified into Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders and Others. 

In the forecast period, the category of cardiovascular disorders is projected to dominate the largest share and the highest growth rate. Some of the factors driving this segment are developments in cardiac MRI procedures in cath-laboratories, beneficial reimbursement policies used for cardiovascular diagnosis contrast media, and strong healthcare infrastructure in developed countries.

Based on the application segment, the market is bifurcated into radiology, interventional radiology, interventional cardiology and others. It is anticipated that the radiology segment will dominate the largest share of the global media contrast market in 2018. Nonetheless, the segment of interventional cardiology is expected to grow at the fastest CAGR. Growth in the cardiology intervention segment can be largely attributed to factors such as increased demand for minimally invasive operations worldwide and increased cardiovascular disease burden.

Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. The North American market is expected to be the biggest share of the global contrast media market. The Asia Pacific market is expected to expand at the highest CAGR in the predictive era. This increase can be attributed to increased R&D investment and a positive demographic scenario in China.

Some of the players included in Contrast Media market are Bayer HealthCare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, J.B. Chemicals and Pharmaceuticals, Lantheus, Spago Nanomedicine, Taejoon Pharm and Unijules Life Sciences amongst others.

The report segments global Contrast Media market as follows:

Global Contrast Media Market: Type Segment Analysis

• Barium-based Contrast Media
• Iodinated Contrast Media
• Gadolinium-based Contrast Media
• Microbubble Contrast Media

Global Contrast Media Market: Modality Segment Analysis

• X-ray/Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound

Global Contrast Media Market: Route of Administration Segment Analysis

• Oral
• Intravascular
• Rectal
• Other Routes

Global Contrast Media Market: Indication Segment Analysis

• Cardiovascular Disorders
• Cancer
• Gastrointestinal Disorders
• Musculoskeletal Disorders
• Neurological Disorders
• Nephrological Disorders
• Others

Global Contrast Media Market: Application Segment Analysis

• Radiology
• Interventional Radiology
• Interventional Cardiology
• Others

Global Contrast Media Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com